Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE19939301112Aexternal-prioritypatent/SE9301112D0/en
Application filed by Orion Yhtymae OyfiledCriticalOrion Yhtymae Oy
Publication of NO944631LpublicationCriticalpatent/NO944631L/en
Publication of NO944631D0publicationCriticalpatent/NO944631D0/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
En stabil fast sammensetning som egner seg for oral tilførsel innbefattende et farmasøytisk akseptabelt syre-addisjonssalt av selegilin oppnås ved å redusere destabi-liseringseffekten av det konvensjonelle smøremidlet som er tilstede i slike sammensetninger, magnesiumstearat, enten ved å erstatte alt eller en vesentlig del av magne-siumstearatet med andre smøremidler slik som fettsyre-estere av vegetabilske oljer og/eller ved tilsats av en farmasøytisk akseptabel syre til selegilininnholdende. tabletter.A stable solid composition suitable for oral administration including a pharmaceutically acceptable acid addition salt of selegiline is obtained by reducing the destabilizing effect of the conventional lubricant present in such compositions, magnesium stearate, either by replacing all or a substantial portion of magne the sodium stearate with other lubricants such as fatty acid esters of vegetable oils and / or by the addition of a pharmaceutically acceptable acid to selegiline-containing. pills.
Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders.
RETINOIDS REPLACED WITH A DIETARY CYCLE AND ITS EMPLOYMENT, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS, COSMETIC AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THERAPEUTIC EMPLOYMENT OF THE latter.